Sign In

Also in this Section

The central purpose of the Nonalcoholic Fatty Liver Disease (NAFLD) SIG is to provide a forum to share ideas, foster collaboration and brainstorm together as an academy of basic and translational investigators. Our mission is to study the pathogenesis, diagnosis, natural history and development of therapeutics for nonalcoholic liver disease. The NAFLD SIG sponsors programs at the AASLD Annual Meeting, identifies emerging topics in NAFLD, and supports the educational mission of AASLD.

SIG Leadership

  • Rohit Loomba, MD
  • Stephen A. Harrison, MD, FAASLD
  • Kathleen E. Corey, MD, MPH, MMSc
  • Manal F. Abdelmalek, MD, MPH, FAASLD
    Steering Committee
  • Leon A. Adams, MBBS, PhD
    Steering Committee
  • Stephen H. Caldwell, MD, FAASLD
    Steering Committee
  • Zachary Henry, MD
    Steering Committee
  • Silvia C. Sookoian, MD, PhD, FAASLD
    Steering Committee